Evidence map›Paper›PMID 25523454›Full record

ArticlemAbs2015

Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".

Jennifer L Percival-Alwyn, Elizabeth England, Benjamin Kemp, Laura Rapley, Nicola H E Davis, Grant R McCarthy, Jayesh B Majithiya, Dominic J Corkill, Sarah Welsted, Kevin Minton and 7 more

Open access · goldAbstract read
In one paragraph

Article in mAbs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jennifer L Percival-Alwyna Department of Antibody Discovery and Protein Engineering; MedImmune Ltd. ; Abington , UK.
Elizabeth England
Benjamin Kemp
Laura Rapley
Nicola H E Davis
Grant R McCarthy
Jayesh B Majithiya
Dominic J Corkill
Sarah Welsted
Kevin Minton
E Suzanne Cohen
Matthew J Robinson
Claire Dobson
Trevor C I Wilkinson
Tristan J Vaughan
Maria A T Groves
Natalie J Tigue

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunization of mice or rats with a "non-self" protein is a commonly used method to obtain monoclonal antibodies, and relies on the immune system's ability to recognize the immunogen as foreign. Immunization of an antigen with 100% identity to the endogenous protein, however, will not elicit a robust immune response. To develop antibodies to mouse proteins, we focused on the potential for breaking such immune tolerance by genetically fusing two independent T-cell epitope-containing sequences (from tetanus toxin (TT) and diphtheria toxin fragment A (DTA)) to a mouse protein, mouse ST2 (mST2). Wild-type CD1 mice were immunized with three mST2 tagged proteins (Fc, TT and DTA) and the specific serum response was determined. Only in mice immunized with the T-cell epitope-containing antigens were specific mST2 serum responses detected; hybridomas generated from these mice secreted highly sequence-diverse IgGs that were capable of binding mST2 and inhibiting the interaction of mST2 with its ligand, mouse interleukin (IL)-33 (mIL-33). Of the hundreds of antibodies profiled, we identified five potent antibodies that were able to inhibit IL-33 induced IL-6 release in a mast cell assay; notably one such antibody was sufficiently potent to suppress IL-5 release and eosinophilia infiltration in an Alternaria alternata challenge mouse model of asthma. This study demonstrated, for the first time, that T-cell epitope-containing tags have the ability to break tolerance in wild-type mice to 100% conserved proteins, and it provides a compelling argument for the broader use of this approach to generate antibodies against any mouse protein or conserved ortholog.

Indexed as

Antibody SpecificityAnimalsAntibodies, Monoclonal, Murine-DerivedAsthmaCell Line, TransformedDiphtheria ToxinEpitopes, T-LymphocyteFemaleHumansInterleukin-1 Receptor-Like 1 ProteinMiceMice, Inbred BALB CRatsReceptors, InterleukinTetanus ToxinAntibodies, Monoclonal, Murine-DerivedDiphtheria ToxinEpitopes, T-LymphocyteIl1rl1 protein, mouseInterleukin-1 Receptor-Like 1 ProteinReceptors, InterleukinTetanus ToxinAntibody generationAPC, antigen presenting cellsCDR, complementarity determining regionCHO, Chinese hamster ovarydiphtheria toxinDMEM, dulbecco's modified eagles' mediumDTA, diphtheria toxinELISA, enzyme-linked immunosorbent assayHLA, human leukocyte antigenHTRF, homogenous time-resolved fluorescencehybridomaIgG, immunoglobulin GILC2, type 2 innate lymphoid cellsIL, interleukinimmunological toleranceMHC, major histocompatibility complexmouse ST2mST2, mouse ST2PADRE, pan HLA-DR-binding T cell epitopeSDS-PAGE, sodium dodecyl sulfate-polyacrylamide gelSLE, systemic lupus erythematosusT-cell epitopesTCR, T cell receptortetanus toxinTT, tetanus tosxinVH, variable region of immunoglobulin heavy chainVL, variable region of immunoglobulin light chain

Identifiers

PMID25523454
PMCPMC4622073
OpenAlexW2033710232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.